Evidence map›Paper›PMID 41904302›Full record

ReviewEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Efficacy and safety of mepolizumab in the treatment of CRSwNP in the real-life setting: a review of the literature.

Pietro Orlando, Letizia Flammia, Emanuele Vivarelli, Andrea Matucci, Alessandra Vultaggio, Oreste Gallo, Giandomenico Maggiore

Abstract readReview
PubMed Publisher
In one paragraph

Review in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pietro OrlandoOtorhinolaryngology Clinic, Careggi University Hospital, Florence, Italy. pietro.orlando@unifi.it.ORCID http://orcid.org/0000-0002-2372-2407
Letizia FlammiaOtorhinolaryngology Clinic, Careggi University Hospital, Florence, Italy.
Emanuele VivarelliUnit of Immunology, Careggi University Hospital, Florence, Italy.
Andrea MatucciUnit of Immunology, Careggi University Hospital, Florence, Italy.
Alessandra VultaggioUnit of Immunology, Careggi University Hospital, Florence, Italy.
Oreste GalloOtorhinolaryngology Clinic, Careggi University Hospital, Florence, Italy.
Giandomenico MaggioreAudiology and Otorhinolaryngology Unit, Careggi University Hospital, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRSwNPMepolizumabQuality of lifeReal-life reviewType-2 comorbidities

Identifiers

PMID41904302

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.